On February 1, the European Commission announced that it had approved Sanofi and Zealand Pharma’s GLP-1 agonist Lyxumia (lixisenatide) for type 2 diabetes. The drug is a...

Kelly reflects on a major advance in obesity treatment and highlights a memorable day for diabetes at the Major League Baseball Hall of Fame.

(S)he said what!?

On November 13, Valeritas announced early user results for its V-Go Disposable Insulin Delivery Device. The small study tracked 23 people with type 2 diabetes using the...

(S)he said what?!?

Ever wondered if we have it better or worse than other countries? Dr. Dorothee Deiss reveals the state of diabetes care in Germany.

They say that bad things come in threes. This certainly held true for up-and-coming obesity medications in late 2010 and early 2011, when Arena’s Belviq (formerly called...

The Centers for Disease Control and Prevention (CDC) recently released a report tracking the skyrocketing prevalence of diabetes throughout all fifty states, the...

Main themes from AACE.

Dr. Sanjay Kaul speaks to diaTribe about the new SGLT-2 drug class.

During the US Open tennis tournament earlier this month, Larry Soler of the Partnership for a Healthier America (PHA) announced a pair of new initiatives to promote...

The American Diabetes Association (Association) held a Facebook chat on the afternoon of January 30 to discuss issues about diabetes and discrimination. The chat was...

(S)he said what?!?

The past few months have seen the approval of a pair of new drugs designed to treat obesity, Arena’s Belviq (see new now next in diaTribe #44) and Vivus’ Qsymia (see new...

Retrofit CEO Jeff Hyman explains what makes data-driven weight loss – using Skype sessions and Wifi scales– so different.

On June 27, the FDA approved Arena Pharmaceutical’s weight-loss drug Belviq (lorcaserin), the first weight-loss drug to be approved in the US in 13 years. Belviq is...

What was it like when you were diagnosed with diabetes? A Sweet Life’s Jessica Apple details a new collection of stories.

This month, the American Journal of Preventive Medicine (AJPM) and the Robert Wood Johnson Foundation announced the start of The Childhood Obesity Challenge, a...

The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...

A new book on diabetes gives patients a nice framework for their care.